[144] CME Group Inc. SEC Filing

Rhea-AI Filing Summary

CME Group Inc. (CME) Form 144 notice reports a proposed sale of 32,468 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $200,054.83 and approximate sale date of 08/18/2025. The shares were acquired as restricted stock from the issuer on 05/02/2024 and were fully paid on that date. The filing lists 360,377,042 shares outstanding. Certain fields such as the identity or relationship of the selling person and the filing contact details are not populated in the provided text. The filer represents they are not aware of undisclosed material adverse information and affirms the signature and certification language required by Form 144.

Positive

• Transaction details provided: class, broker, share count, market value, acquisition date, and sale date are all stated
• Acquisition basis disclosed: shares were acquired as restricted stock from the issuer on 05/02/2024
• Form 144 certifications included: seller represents no undisclosed material adverse information and includes required signature language

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale notice for restricted shares; transaction size and timing are clearly stated without material corporate developments.

The filing documents a proposed sale of 32,468 restricted shares acquired from the issuer on 05/02/2024, with an aggregate market value of $200,054.83 and an anticipated sale date of 08/18/2025 via Morgan Stanley Smith Barney LLC on NASDAQ. The notice contains standard certifications required under Rule 144 but does not provide the seller's relationship to the issuer or contact details in the excerpt provided. For investors, this appears to be a compliance filing to register an intended sale rather than disclosure of operational or financial developments.

Compliance/Risk Analyst

TL;DR: Form 144 appears completed for a restricted-stock disposition; required seller representations are present though some identifying fields are blank.

The notice includes required transaction details: class of security, broker name, number of shares, market value, outstanding shares, acquisition date and nature (restricted stock), and payment information. The certification language affirming lack of undisclosed material adverse information and warning about false statements is included. Missing or blank fields in the provided excerpt—such as filer contact information and the seller's stated relationship to the issuer—should be confirmed in the full filing record to ensure regulatory completeness.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32468	200054.83	360377042	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2024	Restricted Stock	Issuer			32468	05/02/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CME Form 144 filing disclose about the proposed sale?

The filing discloses a proposed sale of 32,468 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $200,054.83, expected around 08/18/2025 on NASDAQ.

When and how were the securities being sold acquired according to the filing?

The securities were acquired as restricted stock from the issuer on 05/02/2024 and payment was recorded as made on that date.

How many shares of CME are reported outstanding in this notice?

The filing lists 360,377,042 shares outstanding.

Does the Form 144 filing state the seller's relationship to CME?

The provided excerpt does not populate the seller's relationship to the issuer; that field is not shown in the supplied content.

Which broker is handling the proposed sale in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.